Published in J Hum Hypertens on November 13, 2014
MicroRNAs in cardiovascular disease: an introduction for clinicians. Heart (2015) 1.38
MicroRNAs and Endothelial (Dys) Function. J Cell Physiol (2015) 0.93
Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders. Pharmacol Rev (2016) 0.87
Signatures of miR-181a on renal transcriptome and blood pressure. Mol Med (2015) 0.77
Vitamin D deficiency and essential hypertension. J Am Soc Hypertens (2015) 0.76
A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism. Mol Psychiatry (2016) 0.75
Expression and methylation of circulating microRNA-510 in essential hypertension. Hypertens Res (2016) 0.75
Anti-Hypertensive Herbs and Their Mechanisms of Action: Part II. Front Pharmacol (2016) 0.75
miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res (2013) 13.41
Comparative analyses of multi-species sequences from targeted genomic regions. Nature (2003) 13.31
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Non-coding RNAs in human disease. Nat Rev Genet (2011) 11.40
Natural RNA circles function as efficient microRNA sponges. Nature (2013) 8.93
Circular RNAs are a large class of animal RNAs with regulatory potency. Nature (2013) 8.54
MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet (2012) 5.38
Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep (2001) 4.74
Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods (2013) 3.63
Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature (2014) 3.31
Human housekeeping genes, revisited. Trends Genet (2013) 2.95
Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet (2007) 2.62
Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation (2011) 2.60
Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci U S A (2013) 1.79
The amazing complexity of the human transcriptome. Eur J Hum Genet (2005) 1.74
Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans. Int J Mol Sci (2013) 1.61
Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol (2012) 1.48
Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res (2011) 1.47
A common genetic variant in the 3'-UTR of vacuolar H+-ATPase ATP6V0A1 creates a micro-RNA motif to alter chromogranin A processing and hypertension risk. Circ Cardiovasc Genet (2011) 1.47
Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension (2011) 1.36
Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab (2012) 1.31
Cardiac tissue engineering: state of the art. Circ Res (2014) 1.30
Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res (2013) 1.30
Potential roles of microRNAs in regulating long intergenic noncoding RNAs. BMC Med Genomics (2013) 1.19
Atrial natriuretic peptide is negatively regulated by microRNA-425. J Clin Invest (2013) 1.17
Heritability and genome-wide linkage in US and australian twins identify novel genomic regions controlling chromogranin a: implications for secretion and blood pressure. Circulation (2008) 1.12
Recent insights and novel bioinformatics tools to understand the role of microRNAs binding to 5' untranslated region. Int J Mol Sci (2012) 1.12
Identification of a novel polymorphism in the 3'UTR of the L-arginine transporter gene SLC7A1: contribution to hypertension and endothelial dysfunction. Circulation (2007) 1.05
SNPs in microRNA binding sites in 3'-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction. Am J Hypertens (2011) 1.03
Fibroblast growth factor 1 gene and hypertension: from the quantitative trait locus to positional analysis. Circulation (2007) 1.02
Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens (2010) 1.02
Mechanistic insights into the link between a polymorphism of the 3'UTR of the SLC7A1 gene and hypertension. Hum Mutat (2009) 1.00
Competing targets of microRNA-608 affect anxiety and hypertension. Hum Mol Genet (2014) 0.99
Urinary exosome miRNome analysis and its applications to salt sensitivity of blood pressure. Clin Biochem (2013) 0.99
Pathway analysis shows association between FGFBP1 and hypertension. J Am Soc Nephrol (2011) 0.95
Advances in blood pressure genomics. Circ Res (2013) 0.94
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. Expert Opin Ther Targets (2013) 0.93
Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension. J Hum Hypertens (2013) 0.92
MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage. J Am Soc Hypertens (2014) 0.90
Role of the sympathetic nervous system in Schlager genetically hypertensive mice. Hypertension (2009) 0.89
Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. J Am Coll Cardiol (2009) 0.87
Non-coding RNAs: the "dark matter" of cardiovascular pathophysiology. Int J Mol Sci (2013) 0.87
An miR-143 promoter variant associated with essential hypertension. Int J Clin Exp Med (2014) 0.86
A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH/2J genetically hypertensive mice. Hypertension (2013) 0.85
Phenotypic characterization of miR-92a-/- mice reveals an important function of miR-92a in skeletal development. PLoS One (2014) 0.84
MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension. Hum Mol Genet (2013) 0.83
Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: Is There a MicroRNA Connection? Int J Hypertens (2010) 0.81
Chromogranin A: a novel susceptibility gene for essential hypertension. Cell Mol Life Sci (2009) 0.81
Contribution of renin-angiotensin system to exercise-induced attenuation of aortic remodeling and improvement of endothelial function in spontaneously hypertensive rats. Cardiovasc Pathol (2014) 0.81
Circulating progenitor cells in hypertensive patients with different degrees of cardiovascular involvement. J Hum Hypertens (2014) 0.80
Non-coding RNAs in cardiovascular ageing. Ageing Res Rev (2014) 0.79